CLDX Celldex Therapeutics, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

CLDX [NASD]

Celldex Therapeutics, Inc.

Healthcare | Biotechnology | USA

financial highlights | statements

Index	-	P/E	-	EPS (ttm)	-4.54	Insider Own	0.36%	Shs Outstand	14.14M	Perf Week	1.86%
Market Cap	30.97M	Forward P/E	-	EPS next Y	-3.37	Insider Trans	0.00%	Shs Float	13.73M	Perf Month	-6.81%
Income	-50.30M	PEG	-	EPS next Q	-1.21	Inst Own	25.80%	Short Float	7.44%	Perf Quarter	-29.81%
Sales	6.90M	P/S	4.49	EPS this Y	-10.70%	Inst Trans	1.47%	Short Ratio	4.86	Perf Half Y	-62.63%
Book/sh	7.40	P/B	0.30	EPS next Y	29.80%	ROA	-	Target Price	19.00	Perf Year	-65.40%
Cash/sh	5.75	P/C	0.38	EPS next 5Y	-	ROE	-	52W Range	2.01 - 11.62	Perf YTD	-26.23%
Dividend	-	P/FCF	-	EPS past 5Y	1.10%	ROI	-125.40%	52W High	-81.15%	Beta	3.52
Dividend %	-	Quick Ratio	7.30	Sales past 5Y	18.30%	Gross Margin	-	52W Low	8.96%	ATR	0.14
Employees	137	Current Ratio	7.30	Sales Q/Q	-75.00%	Oper. Margin	-	RSI (14)	44.49	Volatility	7.25% 6.99%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-	Profit Margin	-	Rel Volume	1.41	Prev Close	2.14
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 07 AMC	Payout	-	Avg Volume	210.10K	Price	2.19
Recom	2.00	SMA20	0.76%	SMA50	-9.55%	SMA200	-45.09%	Volume	295,477	Change	2.34%

Aug-01-17

Resumed

H.C. Wainwright

Buy

$10

Nov-07-16

Initiated

Aegis Capital

Buy

Mar-08-16

Downgrade

Jefferies

Buy → Hold

Mar-07-16

Downgrade

Wedbush

Outperform → Neutral

Mar-07-16

Downgrade

Leerink Partners

Outperform → Mkt Perform

Mar-07-16

Downgrade

Guggenheim

Buy → Neutral

Mar-01-16

Initiated

H.C. Wainwright

Buy

$25

Aug-11-15

Reiterated

ROTH Capital

Buy

$43 → $39

Aug-11-15

Reiterated

Oppenheimer

Outperform

$45 → $42

Aug-11-15

Reiterated

Brean Capital

Buy

$35 → $31

Jun-02-15

Reiterated

WBB Securities

Strong Buy

$30 → $40

Nov-17-14

Reiterated

ROTH Capital

Buy

$40 → $43

Mar-04-14

Reiterated

Oppenheimer

Outperform

$40 → $36

Jul-08-13

Reiterated

Cantor Fitzgerald

Buy

$16 → $24

Mar-08-13

Reiterated

Cantor Fitzgerald

Buy

$13 → $16

Feb-26-13

Reiterated

Oppenheimer

Outperform

$10 → $13

Jan-10-13

Reiterated

Cantor Fitzgerald

Buy

$9 → $13

Oct-02-12

Reiterated

Oppenheimer

Outperform

$6 → $8

Sep-14-12

Reiterated

Cantor Fitzgerald

Buy

$7 → $9

Apr-04-12

Initiated

Cantor Fitzgerald

Buy

Aug-14-19 09:10AM	Kadmon (KDMN) Completes Enrollment in KD025 Study for cGVHD Zacks
04:24AM	Edited Transcript of CLDX earnings conference call or presentation 7-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-13-19 11:53AM	Mallinckrodt Enrolls First Patient in Liver Disease Study Zacks +5.21%
09:50AM	Regeneron Ebola Treatment Shows Promise, Study Stopped Early Zacks
Aug-08-19 04:23PM	Celldex Therapeutics Inc (CLDX) Q2 2019 Earnings Call Transcript Motley Fool
10:54AM	Celldex (CLDX) Q2 Loss Narrower Than Expected, Revenues Miss Zacks
06:00AM	Celldex Therapeutics Keeps Up Its Penny-Pinching and Pipeline Progress Motley Fool
Aug-07-19 06:45PM	Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates Zacks
Jul-31-19 04:01PM	Celldex to Report Second Quarter 2019 Financial Results and Host Corporate Update Call GlobeNewswire
Jun-24-19 08:01AM	Celldex Therapeutics Appoints Diane C. Young, M.D. as Senior Vice President, Chief Medical Officer GlobeNewswire
Jun-06-19 09:31AM	Why Is Celldex (CLDX) Down 29.2% Since Last Earnings Report? Zacks
Jun-04-19 10:26AM	Celldex Presents Data From CDX-3379 Study at ASCO, Stock Down Zacks
07:45AM	The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-Tender Offer Benzinga
Jun-01-19 02:15PM	Celldex Announces Data from CDX-3379 Clinical Program Presented at ASCO 2019; Promising Biomarker Strategy Identified for Head and Neck Squamous Cell Carcinoma GlobeNewswire
May-26-19 05:03PM	The Week Ahead In Biotech: ASCO Presentations In The Spotlight Benzinga
May-14-19 12:36PM	Wall Street Sees 3 Falling Knives Rebounding Within 52 Weeks GuruFocus.com
May-08-19 07:00AM	Celldex Therapeutics Continues to Stretch Out Its Cash and Advance Its Pipeline Motley Fool
May-07-19 06:15PM	Celldex Therapeutics (CLDX) Reports Q1 Loss, Tops Revenue Estimates Zacks
05:09PM	Celldex: 1Q Earnings Snapshot Associated Press
04:01PM	Celldex Provides Corporate Update and Reports First Quarter 2019 Results GlobeNewswire
May-02-19 10:32AM	Celldex Therapeutics (CLDX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
Apr-06-19 09:30AM	Celldex (CLDX) Down 5.7% Since Last Earnings Report: Can It Rebound? Zacks
Apr-02-19 08:00AM	Celldex Presents Positive Interim Results from Phase 1 Study of CD40 Agonist CDX-1140 at American Association for Cancer Research (AACR) Annual Meeting 2019 GlobeNewswire -11.39%
Apr-01-19 01:00PM	Celldex Presents Promising Data from CDX-527 Bispecific and TAM Receptor Programs at American Association for Cancer Research (AACR) Annual Meeting 2019 GlobeNewswire
Mar-20-19 09:30AM	Is Celldex Therapeutics (CLDX) Stock Outpacing Its Medical Peers This Year? Zacks
Mar-13-19 01:19PM	Edited Transcript of CLDX earnings conference call or presentation 7-Mar-19 9:30pm GMT Thomson Reuters StreetEvents
Mar-08-19 11:04AM	Celldex (CLDX) Q4 Loss Narrower than Expected, Sales Beat Zacks +10.87%
07:45AM	Celldex Therapeutics' Cost-Cutting and Reverse Stock Split Help Keep It Rolling Motley Fool
Mar-07-19 07:44PM	Celldex Therapeutics, Inc (CLDX) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:01PM	Celldex Provides Corporate Update and Reports Full Year 2018 Results GlobeNewswire
07:48AM	Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO Benzinga
Feb-22-19 05:50PM	Celldex Therapeutics (CLDX) Stock Sinks As Market Gains: What You Should Know Zacks
Feb-20-19 08:25AM	Analysis: Positioning to Benefit within Applied Materials, MRC Global, Meritor, Celldex Therapeutics, Quaker Chemical, and Cubic Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-14-19 10:45AM	The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna Zacks -6.51%
Feb-13-19 08:36AM	5 Tiny Biotech Stocks With Superb Growth Potential Zacks +10.82%
Feb-11-19 12:26PM	The Celldex Reverse Stock Split: What Investors Need To Know Benzinga -19.03%
09:55AM	Biotech Stocks To Watch ACCESSWIRE
Feb-08-19 11:45AM	Celldex Therapeutics Announces Reverse Stock Split GlobeNewswire -31.17%
Feb-05-19 09:20AM	4 Healthcare Stocks The Market is Watching on Tuesday (2/5/19) ACCESSWIRE -16.04%
08:30AM	Biotech Stocks to Watch ACCESSWIRE
Feb-04-19 02:35PM	These 4 Tech Stocks Could Set February Highs ACCESSWIRE +19.35%
Jan-29-19 08:30AM	Cannabis and Biotech Stocks that Could Explode ACCESSWIRE
Jan-23-19 08:30AM	Best Ways to Play Biotech Rally ACCESSWIRE
Jan-21-19 08:30AM	A Biotech Play You Can't Afford To Miss ACCESSWIRE
Dec-21-18 08:15PM	Here's Why Celldex Therapeutics Sank on Friday Motley Fool -13.08%
Dec-10-18 12:24PM	Why Celldex Therapeutics Is Jumping Today Motley Fool +6.61%
Nov-26-18 08:35AM	Analysis: Positioning to Benefit within Celldex Therapeutics, InnSuites Hospitality Trust, Keryx Biopharmaceuticals, EMX Royalty, FTE Networks, and Xinyuan Real Estate Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-10-18 08:01AM	Celldex Presents Emerging MerTK Antibody Program at the Society for Immunotherapy of Cancers 33rd Annual Meeting GlobeNewswire
Nov-09-18 08:12AM	Celldex (CLDX) Q3 Earnings Beat Estimates, Revenues Miss Zacks
08:01AM	Celldex Presents Promising Interim Data from Phase 1 Study of Differentiated CD40 Agonist CDX-1140 at the Society for Immunotherapy of Cancers 33rd Annual Meeting GlobeNewswire
Nov-08-18 05:48PM	Here's Why Celldex Therapeutics, Inc. Surged on Thursday Motley Fool +12.79%
08:45AM	Celldex Therapeutics Inc. Chugs Along in the 3rd Quarter Despite Challenges Motley Fool
Nov-07-18 06:55PM	Celldex Therapeutics (CLDX) Reports Q3 Loss, Lags Revenue Estimates Zacks
05:49PM	Celldex: 3Q Earnings Snapshot Associated Press
04:01PM	Celldex Provides Corporate Update and Reports Third Quarter 2018 Results GlobeNewswire
Nov-01-18 03:51PM	Why Shares of Celldex Therapeutics, Inc. Sailed Higher Today Motley Fool +10.02%
Oct-22-18 03:18PM	Why Celldex Therapeutics, Inc. Fell on Monday Motley Fool -10.60%
Oct-09-18 07:50AM	Report: Developing Opportunities within Adamis Pharmaceuticals, Cass Information, Celldex Therapeutics, Par Pacific, Inovio Pharmaceuticals, and Liberty Global Future Expectations, Projections Moving into 2018 GlobeNewswire
Sep-18-18 09:04AM	What Investors Should Know About Celldex Therapeutics Incs (NASDAQ:CLDX) Financial Strength Simply Wall St.
Sep-07-18 09:30AM	Why Is Celldex (CLDX) Up 3.3% Since Last Earnings Report? Zacks
Aug-23-18 03:03PM	Why Celldex Therapeutics Inc. Shares Jumped on Wednesday Motley Fool -5.52%
08:00AM	Today's Research Reports on Trending Tickers: Celldex Therapeutics and Inovio Pharmaceuticals ACCESSWIRE
Aug-09-18 10:04AM	Celldex (CLDX) Q2 Earnings and Revenues Surpass Estimates Zacks -6.76%
06:30AM	Celldex Therapeutics, Inc. Spending Cuts Help Preserve Cash in the 2nd Quarter Motley Fool
Aug-08-18 07:50PM	Celldex Therapeutics (CLDX) Reports Q2 Loss, Tops Revenue Estimates Zacks +5.18%
06:44PM	Celldex: 2Q Earnings Snapshot Associated Press
04:01PM	Celldex Provides Corporate Update and Reports Second Quarter 2018 Results GlobeNewswire
02:30PM	Celldex Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 08:01AM	Celldex to Report Second Quarter 2018 Financial Results and Host Corporate Update Call GlobeNewswire
Aug-01-18 07:45AM	Research Report Identifies Myriad Genetics, Celldex Therapeutics, Charles River Laboratories International, Louisiana-Pacific, Integrated Device Technology, and Beazer Homes with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire -5.48%
Jul-30-18 09:55AM	What's in Store for Celldex (CLDX) This Earnings Season? Zacks
Jul-27-18 07:35AM	Initiating Free Research Reports on Celgene and Three Other Biotech Equities ACCESSWIRE -5.89%
Jul-02-18 02:18PM	How David Gardner's Biggest Losers Demonstrate Why Long-Term Investing Wins Motley Fool
Jun-29-18 08:17AM	Better Buy: Ziopharm Oncology, Inc. vs. Celldex Therapeutics Motley Fool
Jun-21-18 08:00AM	Complimentary Technical Snapshots on Celgene and Three More Biotech Stocks ACCESSWIRE
Jun-11-18 06:32AM	Celldex Therapeutics (CLDX) Down 9.2% Since Earnings Report: Can It Rebound? Zacks
Jun-02-18 04:12PM	Celldex Presents Promising Data from Phase 1/2 Study of Varlilumab and Opdivo® at 2018 ASCO Annual Meeting GlobeNewswire
Jun-01-18 11:30AM	Celldex Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference GlobeNewswire
May-18-18 07:05AM	Audentes Therapeutics and Three More Stocks Under Scanner in the Biotech Space ACCESSWIRE
May-16-18 05:01PM	Celldex Announces Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire
May-15-18 02:43PM	May Insights Into Healthcare Stocks: Celldex Therapeutics Inc (NASDAQ:CLDX) Simply Wall St.
May-11-18 09:59AM	Celldex (CLDX) Q1 Loss Wider Than Expected, Shares Down Zacks
May-10-18 03:16PM	Celldex Therapeutics Moves Forward After Glemba Clinical Failure Motley Fool -6.48%
09:00AM	Celldex (CLDX) Q1 Loss Narrower, Revenues Beat, Shares Down Zacks
08:41AM	Celldex: 1Q Earnings Snapshot Associated Press
08:00AM	Celldex Provides Corporate Update and Reports First Quarter 2018 Results GlobeNewswire
May-03-18 10:24AM	What's in Store for Celldex (CLDX) This Earnings Season? Zacks
Apr-25-18 10:33AM	Lessons to Learn From April's Biotech Blowups Motley Fool
Apr-23-18 11:20AM	Is It Game Over for Celldex? Motley Fool
Apr-22-18 10:50AM	Johnson & Johnson's First-Quarter 2018 Earnings Review Motley Fool
Apr-20-18 08:01AM	Data from Multiple Celldex Programs Presented at American Association for Cancer Research (AACR) Annual Meeting 2018 GlobeNewswire
07:55AM	Analysis: Positioning to Benefit within Celldex Therapeutics, McDermott International, Briggs & Stratton, Tile Shop Hldgs, Essendant, and Anworth Mortgage Asset Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Apr-18-18 10:07AM	Biotech Stock Roundup: ALKS Up, CLDX Down, ALXN to Acquire Wilson Therapeutics Zacks -8.10%
Apr-17-18 09:55AM	Celldex's Phase II Breast Cancer Study Fails, Shares Plunge Zacks
08:10AM	Todays Research Reports on Stocks to Watch: Celldex Therapeutics and Cancer Genetics ACCESSWIRE
Apr-16-18 08:50AM	Why Celldex Therapeutics Stock Is Cratering Today Motley Fool -64.60%
07:45AM	Celldex's stock plummets toward record low after failed drug study MarketWatch
07:00AM	Celldexs METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint GlobeNewswire
Apr-10-18 08:46AM	Implied Volatility Surging for Celldex Therapeutics (CLDX) Stock Options Zacks
Apr-03-18 04:15PM	Celldex Therapeutics Inc (NASDAQ:CLDX): Has Recent Earnings Growth Beaten Long-Term Trend? Simply Wall St.

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of immunotherapies and other cancer-targeting biologics. It develops CDX-1140, an agonist human monoclonal antibody, currently being studied as a single-agent and in combination with CDX-301 in a Phase I dose-escalation study in multiple types of solid tumors and B cell lymphomas; CDX-3379, a human monoclonal antibody designed to block the activity of ErbB3 that is in an early Phase II study in advanced head and neck squamous cell cancer in combination with Erbitux; CDX-301, a dendritic cell growth factor; and Varlilumab, an immune modulating antibody targeting CD27 designed to enhance a patient's immune response. Celldex Therapeutics, Inc. has research collaboration and license agreements with Medarex, Inc.; University of Southampton; Amgen Inc.; Yale University; and MedImmune, LLC. The company is headquartered in Hampton, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MARINO JAMES J	Director	Aug 24	Buy	0.48	40,000	19,200	65,997	Aug 28 07:34 AM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience